Who owns Vertex Pharmaceuticals Incorporated?

Key details on Vertex Pharmaceuticals Incorporated (Ticker: VRTX)

Who owns Vertex Pharmaceuticals Incorporated?

Is VRTX a good stock to own? Find out who bought Vertex Pharmaceuticals Incorporated, who sold Vertex Pharmaceuticals Incorporated (VRTX) stock, and who holds a large position in Vertex Pharmaceuticals Incorporated.

Fund Name Number of Shares Share Valuation As Of
Capital World Investors^ 25.52M $1.90B Dec. 31, 2013
Vanguard 15.73M $1.17B Dec. 31, 2013
Jennison Associates 13.47M $1.00B Dec. 31, 2013
Wellington Management Company 12.10M $917.61M Sept. 30, 2013
STATE STREET CORPORATION 9.64M $716.02M Dec. 31, 2013
T. Rowe Price Associates 9.36M $695.40M Dec. 31, 2013
JPMORGAN CHASE & CO 9.18M $682.09M Dec. 31, 2013
Ameriprise Financial 7.79M $578.91M Dec. 31, 2013
ClearBridge Advisors 6.90M $512.78M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 5.99M $444.91M Dec. 31, 2013
FMR 5.72M $424.76M Dec. 31, 2013
BlackRock Fund Advisors 5.45M $405.30M Dec. 31, 2013
Janus Capital Management 5.09M $405.72M June 30, 2013
GOLDMAN SACHS 4.61M $342.70M Dec. 31, 2013
D. E. Shaw & Co 4.22M $235.76M June 30, 2012
Loomis, Sayles and 3.75M $278.94M Dec. 31, 2013
OppenheimerFunds 3.61M $268.14M Dec. 31, 2013
Waddell & Reed Financial 3.57M $264.93M Dec. 31, 2013
Sectoral Asset Management 3.49M $192.02M March 31, 2013
Brookside Capital Management, LLC* 3.42M $113.48B Dec. 31, 2011
Lazard Asset Management 3.34M $248.34M Dec. 31, 2013
Inves 3.26M $242.02M Dec. 31, 2013
Westfield Capital Management Company 3.10M $129.77M Dec. 31, 2012
ALLIANCEBERNSTEIN 3.09M $129.74M Dec. 31, 2012
Adage Capital Partners GP 3.07M $245.89M June 30, 2013
Neuberger Berman 3.01M $165.45M March 31, 2013
BB Biotech AG 3.00M $99.55M Dec. 31, 2011
NORTHERN TRUST 2.99M $221.81M Dec. 31, 2013